The growth of emerging markets is poised to transform the delivery of surgical care around the world by 2030, according to a new report by product design and development firm Cambridge Consultants. The emphasis will be on affordable technology for early diagnosis; portable modular equipment for minimally invasive and robotic surgery; and smart systems incorporating low-cost sensors and mobile technology to track clinical outcomes and improve team-based surgery.
The report summarises the findings of a workshop held in Boston earlier this year by Cambridge Consultants. It offers unique insight into the future of emerging markets surgical care – as seen through the eyes of industry leaders. And it looks at how these new approaches to healthcare will extend beyond emerging markets to disrupt and transform how affordable quality surgical care is delivered globally.
“More than 85% of the world’s population lives in emerging markets, yet many of these people have no access to affordable quality healthcare, particularly complex treatment like surgery,” said Rahul Sathe, head of surgical innovation for emerging markets, Cambridge Consultants.
“Inadequate hospital infrastructure, a scarcity of qualified clinicians and fragmented healthcare ecosystems prevent successful surgical care. The surgical device industry has unprecedented growth opportunity to address the unmet needs of very large patient populations.”
The report spells out the huge opportunities for technology disruption in emerging markets. Infrastructure and regulations are still being formed, and industry legacy is not particularly strong – offering a lower barrier to innovation compared with developed markets.
The primary role of technology will be twofold, says the report. It can extend the ‘hospital ecosystem’ across the continuum of care from early diagnosis and surgical intervention to postoperative monitoring. It can also ensure products and solutions are robust, usable and affordable – and unlock access to care.